Catherine Bardelle

Industrial scale high-throughput screening delivers multiple fast acting macrofilaricides

Rachel H. Clare, Catherine Bardelle, Paul Harper et al. · Nature Communications · 2018 · 128 citations · Full text

Inhibitors of the tyrosine kinase EphB4. Part 1: Structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines

Catherine Bardelle, Darren A.E. Cross, Sara Davenport et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 55 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Biochemistry +8

Membrane binding kinetics of factor VIII indicate a complex binding process.

Catherine Bardelle, Bruce Furie, Bruce Furie et al. · Journal of Biological Chemistry · 1993 · 55 citations · Full text

Proteinlipid Interaction, Molecular Physiology, Biochemistry +13

Inhibitors of the tyrosine kinase EphB4. Part 2: Structure-based discovery and optimisation of 3,5-bis substituted anilinopyrimidines

Catherine Bardelle, Tanya Coleman, Darren A.E. Cross et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 53 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Drug Target +10

Inhibitors of the tyrosine kinase EphB4. Part 3: Identification of non-benzodioxole-based kinase inhibitors

Catherine Bardelle, Bernard Barlaam, Nigel Brooks et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 35 citations · Full text

Drug Target, Biochemistry, Non-benzodioxole-based Kinase Inhibitors +8